DAY 3 - Tuesday, May 8
ARVO AWARD
Weisenfeld lecturer exemplifies bench-to-bedside research
Fort Lauderdale, FL—Early in his career, John V. Forrester, MD, FRCSE, FRCSG, FRCOpth, FARVO, became a clinician scientist when a patient seeking help for vitreous hemorrhage volunteered to serve as a “guinea pig” for Dr. Forrester and his consultant, willing to take part in experimental treatments that might help his vision and that would also allow Dr. Forrester to investigate the question of why a vitreous hemorrhage did not resolve very well. He shared this journey as the recipient of ARVO’s Mildred Weisenfeld Award, bestowed Monday night. » MORE
NEURO-OPHTHALMOLOGY
SLP has outcome-predictive potential in NAION
Fort Lauderdale, FL—Scanning laser polarimetry (SLP) seems to have good ability to predict the visual field and retinal nerve fiber loss outcomes compared with evaluation of images over time in patients with nonarteritic ischemic optic neuropathy (NAION). The SLP results are not correlated with optical coherence tomography (OCT) outcomes, according to Mark J. Kupersmith, MD. » MORE
Pilot study: Papillary thickness in optic nerve head edema
Fort Lauderdale, FL—A spectral-domain optical coherence tomography (SD-OCT) star-pattern scan (SPS) acquisition protocol may be a more accurate and sensitive baseline measure for the diagnosis and follow-up of papilledema than presently used methods, according to the results of a pilot study, said Mazen Y. Choulakian, MD. » MORE
Study uses MRI to assess mechanisms in IIH
Fort Lauderdale, FL—Measures of total cranial, ventricular, and extraventricular cerebrospinal fluid (CSF) volumes in idiopathic intracranial hypertension (IIH) provide strong evidence that at least two mechanisms are involved in this condition, said Byron L. Lam, MD. » MORE
Subretinal prosthesis advances toward clinical trial
Fort Lauderdale, FL—The 256+ channel Boston subretinal prosthesis is on track for in vivo validation of function and an FDA investigational device exemption application within the next 9 months, according to Joseph F. Rizzo III, MD. » MORE
GLAUCOMA
Latanoprost enhances lymphatic drainage in murine model
Fort Lauderdale, FL—Latanoprost 0.005% (Xalatan, Pfizer), a prostaglandin analogue, stimulates lymphatic drainage in normal mouse eyes, said Alex Tam, MD, who presented the details of his mouse model and the implications of this research. » MORE
RETINA
Ranibizumab reduces progression of diabetic retinopathy
Fort Lauderdale, FL—Intravitreal ranibizumab (Lucentis, Genentech) reduced the risk and rate of progression of diabetic retinopathy in eyes with diabetic macular edema (DME), and many eyes treated with ranibizumab had improvements in the severity of the diabetic retinopathy, said Michael Ip, MD. » MORE
Disruption of photoreceptor layer related to poor visual acuity
Fort Lauderdale, FL—Spectral-domain optical coherence tomography (SD-OCT) identified disruption of the photoreceptor layer as highly associated with poor visual acuity outcomes in patients with resolved diabetic macular edema (DME), according to Ahmed Soliman, MD. » MORE
DISCLAIMER:
This information has been independently developed and provided by the editors of Ophthalmology Times. The sponsor does not endorse and is not responsible for the accuracy of the content or for practices or standards of non-sponsor sources.
|
